Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Ogueta
Pcv104 - Beta-Blockers, Angiotensin Ii, and Angiotensin-Converting Enzyme Inhibitors in Patients With Heart Failure. Differences in Prescription by Gender, Socioeconomic Status and Comorbidity After a First Hospitalization for Heart Failure
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Up-Titrating Angiotensin-Converting Enzyme Inhibitors in Heart Failure: Evidence and Challenges
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease ― Propensity Score Matching Analysis ―
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Addition of Losartan to Angiotensin-Converting Enzyme Inhibitors Improves Insulin Resistance in Patients With Chronic Heart Failure Treated Without Β-Blockers
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists in Rats With Heart Failure. Role of Kinins and Angiotensin II Type 2 Receptors.
Journal of Clinical Investigation
Medicine
Race and Association of Angiotensin Converting Enzyme/Angiotensin Receptor Blocker Exposure With Outcome in Heart Failure
Journal of Cardiovascular Medicine
Medicine
Cardiovascular Medicine
Cardiology
Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors
CMAJ
Medicine
Effect of Different Angiotensin-Converting-Enzyme Inhibitors on Mortality Among Elderly Patients With Congestive Heart Failure
CMAJ
Medicine
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology
Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
